Downloads: 124
Informative Article | Pharmaceutical Science | India | Volume 8 Issue 12, December 2019
Orphan Drugs
Abstract: An orphan drug is a pharmaceutical agent that is used to treat a rare medical condition (viz. , Huntington’s disease, myoclonus disease, Tourette syndrome etc. ). They receive little attention from pharmaceutical companies as the small patient population could not justify the huge investment required for drug development. In the last 20 years, orphan drug act has been adopted in several countries around the world (USA, Japan, Australia, and the EU) and has successfully promoted R & D investments to develop new pharmaceutical products for the treatment of rare diseases, but it faces future challenges like returns on the huge R & D costs, funding sources and initiatives for development of orphan drugs.
Keywords: Rare disease, Orphan drugs, ODA
Edition: Volume 8 Issue 12, December 2019,
Pages: 1349 - 1355
How to Cite this Article?
Priya Shaju, "Orphan Drugs", International Journal of Science and Research (IJSR), Volume 8 Issue 12, December 2019, pp. 1349-1355, https://www.ijsr.net/get_abstract.php?paper_id=ART20203619
How to Share this Article?
Click below to Watch Video Lecture of Above Article
Similar Articles with Keyword 'ODA'
Downloads: 0
Review Papers, Pharmaceutical Science, India, Volume 11 Issue 5, May 2022
Pages: 1541 - 1547Advancement in Edible Medicated Jelly
Mrynal Chamoli | Shaffi Khurana Tangri
Downloads: 3
Research Paper, Pharmaceutical Science, Libya, Volume 10 Issue 12, December 2021
Pages: 97 - 104Pharmaceutical Evaluation of Some Commercial Brands of Metronidazole 500mg Tablets Marketed in Tripoli Libya
Tamader Y. Elghnimi [2] | Amal A. Ammar | Sakina S. Saadawi [2] | Ashaima M. Algeryani